Clinical Trials Directory

Trials / Completed

CompletedNCT03656900

Monocentric Pilot Study, for a Randomized, Crossover, Blinded Trial: Comparison of the Therapeutic Efficacy of Low Frequency Repeated Transcranial Magnetic Stimulation on Cortical Area 9 Compared to Brodmann Area 46 in the Treatment of Depressive Disorders.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Repetitive transcranial magnetic stimulation (rTMS) is a new therapeutic tool used in psychiatry. Non-invasive, well tolerated and requiring no premedication, it is performed on an outpatient basis. The principle of this technique is to stimulate the cerebral cortex from an electromagnetic coil placed on the scalp. Unlike electroconvulsive therapy, rTMS induces an electrical current on a well-defined region of the cerebral cortex. In psychiatry, this technique is mainly considered in the treatment of depressive disorders resistant to antidepressant medication. The brain target, obtained from brain imaging data in depressed patients, is the dorsolateral prefrontal cortex (DLPFC). The Food and Drug Administration (FDA) has recognized the interest of rTMS for treating depressive disorders (October 7, 2008). However, some stimulation parameters still need to be optimized before rTMS can be considered a therapeutic method in its own right and used routinely. Indeed, its effectiveness over time has not yet been evaluated, and rTMS has shown a lack of reproducibility between subjects \[Foucher, 2007\]. Finally, the therapeutic results of rTMS are very modest whatever the study \[Daskalakis, 2008\]. Additional studies are therefore needed to optimize stimulation parameters.

Conditions

Interventions

TypeNameDescription
DEVICErTMS BA9/BA4610 sessions of low-frequency repeated transcranial magnetic stimulation over two weeks on cortical area 9, then 4 weeks wash-out, then 10 sessions of low-frequency repeated transcranial magnetic stimulation repeated low frequency over two weeks on cortical area 46.
DEVICErTMS BA46/BA910 sessions of low-frequency repeated transcranial magnetic stimulation over two weeks on cortical area 46, then 4 weeks wash-out, then 10 sessions of low-frequency repeated transcranial magnetic stimulation repeated low frequency over two weeks on cortical area 9.
RADIATIONbrain MRIT1 weighted full-head high-resolution MRI with 1 mm seam cuts and sagittal orientation.
OTHERMedical evaluationcomplete evaluation with 6 scales (HDRS, MADRS, Beck, CGI, COVI, UKU)
OTHERPsychological assessmentSubjective Life Profile Assessment (SLPA) and Helping Alliance Assessment

Timeline

Start date
2010-02-01
Primary completion
2011-02-01
Completion
2013-10-01
First posted
2018-09-04
Last updated
2018-09-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03656900. Inclusion in this directory is not an endorsement.